Community Based Organizations

GLP-1 receptor agonists (GLP-1s), including semaglutide, tirzepatide, and liraglutide, are increasingly used for weight management and show promise for people living with HIV (PLWH). While these medications are generally safe, PLWH may face additional considerations when using them due to how GLP-1s function and interact with antiretroviral therapy (ART). GLP-1s slow gastric emptying and suppress appetite, which may affect ART absorption; gastrointestinal side effects such as nausea or vomiting may also interfere with consistent ART dosing.

This infographic from Fair Health draws on data from its NPIC database—over 47 billion commercial medical and dental claims—to highlight rising trends in sexually transmitted disease (STD) diagnoses across various demographics in the U.S. between 2020 and 2023. The visuals show that overall STD diagnoses increased significantly, led by notable rises in syphilis, gonorrhea, and HIV/AIDS.

This webpage discusses the critical role of early testing, diagnosis, and treatment in controlling the spread of tuberculosis (TB) and saving lives. It highlights local efforts to improve TB prevention and care, focusing on the impact of timely intervention on reducing TB transmission in specific communities. 

This video-based HIV and STI prevention intervention designed for patients in STI clinic waiting rooms. This video aims to increase HIV treatment initiation and adherence as well as improve viral suppression and achieve undetectable viral load among patients.

This report proposes policies for expanding access to hepatitis C (HCV) testing and treatment in United States jails and prisons. The report's policy recommendations draw principally from settlement agreements, judicial opinions, and other filings in those cases, supplemented by current medical guidance and input from public health experts, medical professionals, and advocates.

This report lays out the required sections that must be included in a state’s Section 1115 Demonstration application and identifies where and how a state can be explicit about its intent to address the health care needs of individuals with hepatitis C as part of its Justice-Involved Reentry Initiative.

This article highlights a new hepatitis C test that delivers rapid results without requiring a separate lab visit, improving access to early diagnosis and treatment. It emphasizes the importance of expanding testing efforts, particularly for high-risk populations, to support hepatitis C elimination. The article underscores the need for continued innovation in screening technologies to reduce barriers to care and prevent long-term health complications like liver disease and cancer.

In this podcast episode, Anousha and Bright invited Dr. Robert Gish to speak about hepatitis B Reactivation, a serious health issue often overlooked in the discourse surrounding hepatitis B and liver cancer.

More than 2.4 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2023. Still, the numbers show the cases of reportable STIs tended to decrease, or at least saw a sharp decline in the rate by which they increased. In this episode of the Sex+Health podcast, we talk with Bradley Stoner, MD, PhD, the Director of the Centers for Disease Control and Prevention Division of STD Prevention, for his thoughts on what's driving the epidemic and why the latest data show there may be cause for optimism.

NASTAD highlights the achievements of the 47 Ending the HIV Epidemic (EHE) Phase 1 jurisdictions through a series of success stories featured on a dedicated webpage. These stories demonstrate innovative strategies addressing the four pillars of EHE: Diagnose, Treat, Prevent, and Respond. Supported by the Health Resources and Services Administration (HRSA), this initiative aims to strengthen programs for individuals living with and at risk for HIV.